Abstract Body

Background

Sexually transmitted infections (STIs) remain a global public health challenge with the highest burden in low-resource settings where limited screening causes delayed diagnosis and continued transmission. The World Health Organization estimates over 1 million curable STIs occur daily.Human papillomavirus (HPV) is the most common, with high-risk types such as 16, 18, 31, 33, 45, 52 and 58 strongly linked to cervical cancer.Self-sampling offers a promising strategy to decentralize testing.Pharmacies, widely accessed for reproductive health could expand STI services, yet evidence on the feasibility and acceptability of cervico-vaginal self-sampling in these settings is limited.We hypothesized that pharmacy-based self-sampling would be feasible, acceptable and reveal hidden infections

Methods

We conducted a cross-sectional mixed-methods study among women aged 18–49 years visiting selected Nairobi pharmacies.A survey was administered to 350 women to assess experiences and preferences regarding self-sampling.Of these, 100 provided self-collected cervico-vaginal samples and 10 key informant interviews were held with pharmacy staff to explore their perspectives on feasibility.Polymerase chain reaction (PCR) assays tested for STIs and high-risk HPV genotypes

Results

Self-sampling was highly acceptable, with 96.2% citing convenience and privacy.Risky sexual behaviors were common, with 95.2% reporting unprotected sex and 68.3% experiencing genitourinary symptoms, yet only 22.2% had prior STI diagnoses showing screening gaps.Knowledge was moderate but 96.2% expressed positive attitudes.Feasibility was high, with 88% finding the process easy, 91% willing to recommend it and 86% likely to reuse.Pharmacists supported the model but emphasized training and privacy protocols.Laboratory analysis revealed a hidden burden, with 85% positive for at least one STI and 48% for high-risk HPV

Conclusions

Cervico-vaginal self-sampling for STI detection is feasible and acceptable among women accessing Nairobi pharmacies, uncovering a high burden of undiagnosed infections.Pharmacies provide a scalable platform to expand testing, reduce stigma and improve timely diagnosis.However, the gap between positive attitudes and poor preventive practices highlights the need for interventions addressing socioeconomic and psychosocial barriers.Scaling up pharmacy-based self-sampling, with staff training and policy integration,could strengthen STI control and improve women’s reproductive health in low-resource settings